Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Daily News

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

L.A. McKeown

December 20, 2016

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

News Conference News VIVA 2016

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

L.A. McKeown

October 12, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Conference News VIVA 2016

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

L.A. McKeown

September 20, 2016

News Industry News

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

February 08, 2016

News Industry News

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

January 25, 2016

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Daily News

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

L.A. McKeown

September 23, 2015

News Daily News

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

L.A. McKeown

August 05, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

News Industry News

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

July 01, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

News Daily News

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Todd Neale

October 10, 2014

News Daily News

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

L.A. McKeown

June 17, 2014

News Daily News

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

L.A. McKeown

January 20, 2014

News Daily News

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Caitlin E. Cox

June 28, 2013

News Conference News EuroPCR 2013

Novel ‘3D’ Stent Improves Clinical Status in Femoropopliteal Disease Patients

Jason Kahn

May 23, 2013

Advertisement

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Positive Results Continue at 2 Years for Paclitaxel-Eluting PAD Stent

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

First Subject Enrolled in Veryan Medical's MIMICS-2 Study

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

FDA Advisory Panel Gives Nod to Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

STROLL at 3 Years: Nitinol Stent Demonstrates Sustained Patency, QoL in SFA Patients

PTA-First Strategy Matches Primary Stenting for Popliteal Artery Disease

Novel ‘3D’ Stent Improves Clinical Status in Femoropopliteal Disease Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content